首页 > 最新文献

Analytical Cellular Pathology (Amsterdam)最新文献

英文 中文
Reduction of Activin Receptor-Like Kinase 4 Expression Ameliorates Myocardial Ischemia/Reperfusion Injury through Inhibiting TGFβ Signaling Pathway 激活素受体样激酶4表达减少通过抑制TGFβ信号通路改善心肌缺血/再灌注损伤
Pub Date : 2022-03-31 DOI: 10.1155/2022/5242323
Mantian Chen, Yinggang Sun, Qian Wang, Yigang Li
The activation of activin receptor-like kinase 4 (ALK4) signaling plays a pivotal role in the pressure-overloaded heart, and haplodeficiency of ALK4 can alleviate cardiac fibrosis secondary to myocardial infarction and preserve cardiac function through partially inactivating the Smad3/4 pathway. However, whether transforming growth factor (TGF) β signaling is involved in the beneficial effects of ALK4 knockdown on the ischemic heart is still unclear. This study was undertaken to investigate the change in the TGFβ signaling after ALK4 knockdown in vivo and in vitro. Forty C57BL/6J mice were randomized into ALK4+/- ischemia/reperfusion (I/R) group (ALK4+/-+I/R, n = 10), ALK4+/- sham group (ALK4+/-+sham, n = 10), wild-type sham group (WT+sham, n = 10), and WT I/R group (WT+I/R, n = 10). Heart histology and the levels of cytokines related to antioxidant and inflammation, as well as protein and mRNA expressions of molecules associated with TGFβ pathway, were examined in different groups. Our results showed that the reduction of ALK4 expression ameliorated myocardial I/R injury through inhibiting TGFβ signaling pathway. Our findings indicate that ALK4 may become a novel target for the therapy of myocardial I/R injury.
激活素受体样激酶4 (activin receptor-like kinase 4, ALK4)信号的激活在压力过载的心脏中起着关键作用,ALK4单倍体缺失可以通过部分失活Smad3/4通路,减轻心肌梗死继发的心肌纤维化,维持心功能。然而,转化生长因子(TGF) β信号是否参与了ALK4敲低对缺血心脏的有益作用尚不清楚。本研究旨在探讨体内和体外敲除ALK4后tgf - β信号通路的变化。将40只C57BL/6J小鼠随机分为ALK4+/-缺血/再灌注(I/R)组(ALK4+/-+I/R, n = 10)、ALK4+/-假手术组(ALK4+/-+sham, n = 10)、野生型假手术组(WT+sham, n = 10)和WT I/R组(WT+I/R, n = 10)。检测各组心脏组织学、抗氧化和炎症相关细胞因子水平以及TGFβ通路相关分子蛋白和mRNA表达。结果表明,降低ALK4表达可通过抑制tgf - β信号通路改善心肌I/R损伤。我们的研究结果表明,ALK4可能成为心肌I/R损伤治疗的新靶点。
{"title":"Reduction of Activin Receptor-Like Kinase 4 Expression Ameliorates Myocardial Ischemia/Reperfusion Injury through Inhibiting TGFβ Signaling Pathway","authors":"Mantian Chen, Yinggang Sun, Qian Wang, Yigang Li","doi":"10.1155/2022/5242323","DOIUrl":"https://doi.org/10.1155/2022/5242323","url":null,"abstract":"The activation of activin receptor-like kinase 4 (ALK4) signaling plays a pivotal role in the pressure-overloaded heart, and haplodeficiency of ALK4 can alleviate cardiac fibrosis secondary to myocardial infarction and preserve cardiac function through partially inactivating the Smad3/4 pathway. However, whether transforming growth factor (TGF) β signaling is involved in the beneficial effects of ALK4 knockdown on the ischemic heart is still unclear. This study was undertaken to investigate the change in the TGFβ signaling after ALK4 knockdown in vivo and in vitro. Forty C57BL/6J mice were randomized into ALK4+/- ischemia/reperfusion (I/R) group (ALK4+/-+I/R, n = 10), ALK4+/- sham group (ALK4+/-+sham, n = 10), wild-type sham group (WT+sham, n = 10), and WT I/R group (WT+I/R, n = 10). Heart histology and the levels of cytokines related to antioxidant and inflammation, as well as protein and mRNA expressions of molecules associated with TGFβ pathway, were examined in different groups. Our results showed that the reduction of ALK4 expression ameliorated myocardial I/R injury through inhibiting TGFβ signaling pathway. Our findings indicate that ALK4 may become a novel target for the therapy of myocardial I/R injury.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"215 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122843222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway 二甲双胍通过AMPK/NLRP3炎性体通路预防脊髓损伤和细胞焦亡
Pub Date : 2022-03-27 DOI: 10.1155/2022/3634908
Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, Zipeng Zhou, Weiran Gao
Spinal cord injury (SCI) is an extreme neurological impairment with few effective drug treatments. Pyroptosis is a recently found and proven type of programmed cell death that is characterized by a reliance on inflammatory caspases and the release of a large number of proinflammatory chemicals. Pyroptosis differs from other cell death mechanisms such as apoptosis and necrosis in terms of morphological traits, incidence, and regulatory mechanism. Pyroptosis is widely involved in the occurrence and development of SCI. In-depth research on pyroptosis will help researchers better understand its involvement in the onset, progression, and prognosis of SCI, as well as provide new therapeutic prevention and treatment options. Herein, we investigated the role of AMPK-mediated activation of the NLRP3 inflammasome in the neuroprotection of MET-regulated pyroptosis. We found that MET treatment reduced NLRP3 inflammasome activation by activating phosphorylated AMPK and reduced proinflammatory cytokine (IL-1β, IL-6, and TNF-α) release. At the same time, MET improved motor function recovery in rats after SCI by reducing motor neuron loss in the anterior horn of the spinal cord. Taken together, our study confirmed that MET inhibits neuronal pyroptosis after SCI via the AMPK/NLRP3 signaling pathway, which is mostly dependent on the AMPK pathway increase, hence decreasing NLRP3 inflammasome activation.
脊髓损伤(SCI)是一种极端的神经系统损伤,目前缺乏有效的药物治疗。焦亡是最近发现并证实的一种程序性细胞死亡类型,其特点是依赖于炎性半胱天酶和大量促炎化学物质的释放。焦亡与细胞凋亡、坏死等其他细胞死亡机制在形态特征、发生率和调控机制等方面都有不同。焦亡在脊髓损伤的发生和发展中有广泛的参与。对焦亡的深入研究将有助于研究人员更好地了解其与脊髓损伤的发生、进展和预后的关系,并提供新的治疗预防和治疗方案。在此,我们研究了ampk介导的NLRP3炎症小体的激活在met调节的焦亡的神经保护中的作用。我们发现MET治疗通过激活磷酸化的AMPK和减少促炎细胞因子(IL-1β、IL-6和TNF-α)的释放来降低NLRP3炎性体的活化。同时,MET通过减少脊髓前角运动神经元的损失,改善脊髓损伤后大鼠的运动功能恢复。综上所述,我们的研究证实MET通过AMPK/NLRP3信号通路抑制脊髓损伤后神经元焦亡,其主要依赖于AMPK通路的增加,从而降低NLRP3炎性体的激活。
{"title":"Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway","authors":"Yajiang Yuan, Xiangyi Fan, Zhanpeng Guo, Zipeng Zhou, Weiran Gao","doi":"10.1155/2022/3634908","DOIUrl":"https://doi.org/10.1155/2022/3634908","url":null,"abstract":"Spinal cord injury (SCI) is an extreme neurological impairment with few effective drug treatments. Pyroptosis is a recently found and proven type of programmed cell death that is characterized by a reliance on inflammatory caspases and the release of a large number of proinflammatory chemicals. Pyroptosis differs from other cell death mechanisms such as apoptosis and necrosis in terms of morphological traits, incidence, and regulatory mechanism. Pyroptosis is widely involved in the occurrence and development of SCI. In-depth research on pyroptosis will help researchers better understand its involvement in the onset, progression, and prognosis of SCI, as well as provide new therapeutic prevention and treatment options. Herein, we investigated the role of AMPK-mediated activation of the NLRP3 inflammasome in the neuroprotection of MET-regulated pyroptosis. We found that MET treatment reduced NLRP3 inflammasome activation by activating phosphorylated AMPK and reduced proinflammatory cytokine (IL-1β, IL-6, and TNF-α) release. At the same time, MET improved motor function recovery in rats after SCI by reducing motor neuron loss in the anterior horn of the spinal cord. Taken together, our study confirmed that MET inhibits neuronal pyroptosis after SCI via the AMPK/NLRP3 signaling pathway, which is mostly dependent on the AMPK pathway increase, hence decreasing NLRP3 inflammasome activation.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"230 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130517478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
A Semi-supervised Deep Learning Method for Cervical Cell Classification 子宫颈细胞分类的半监督深度学习方法
Pub Date : 2022-02-27 DOI: 10.1155/2022/4376178
Siqi Zhao, Yongjun He, Jian Qin, Zixuan Wang
Currently, the Thinprep cytologic test (TCT) is the most popular cervical cancer cytology test technique. It can detect precancerous conditions and microbial infections. However, this technique entirely relies on manual operation and doctors' naked eye observation, resulting in a heavy workload and low accuracy rate. Recently, automatic pathological diagnosis has been developed to solve this problem. Cervical cell classification is a key technology in the intelligent cervical cancer diagnosis system. Training a deep neural network-based classification model requires a large amount of data. However, cervical cell labeling requires specialized physicians and the cost of labeling is high, resulting in a lack of sufficient labeling data in this field. To address this problem, we propose a method to ensure high accuracy in cervical cell classification with a small amount of labeled data by introducing manual features and a voting mechanism to achieve data expansion in semi-supervised learning. The method consists of three main steps, using a clarity function to filter out high-quality cervical cell images, annotating a small amount of them, and balancing the training data using a voting mechanism. With a small amount of labeled data, the accuracy of the proposed method in this paper can reach to 91.94%.
目前,薄壁细胞学检查(TCT)是最流行的宫颈癌细胞学检查技术。它可以检测癌前病变和微生物感染。但该技术完全依靠人工操作和医生肉眼观察,工作量大,准确率低。为了解决这一问题,近年来出现了病理自动诊断。宫颈细胞分类是智能宫颈癌诊断系统的关键技术。训练基于深度神经网络的分类模型需要大量的数据。然而,宫颈细胞标记需要专科医生,且标记成本高,导致该领域缺乏足够的标记数据。为了解决这一问题,我们提出了一种方法,通过引入人工特征和投票机制来实现半监督学习中的数据扩展,从而在少量标记数据的情况下保证宫颈细胞分类的高精度。该方法包括三个主要步骤:使用清晰度函数过滤出高质量的宫颈细胞图像,对少量图像进行注释,以及使用投票机制平衡训练数据。在标记数据较少的情况下,本文方法的准确率可达91.94%。
{"title":"A Semi-supervised Deep Learning Method for Cervical Cell Classification","authors":"Siqi Zhao, Yongjun He, Jian Qin, Zixuan Wang","doi":"10.1155/2022/4376178","DOIUrl":"https://doi.org/10.1155/2022/4376178","url":null,"abstract":"Currently, the Thinprep cytologic test (TCT) is the most popular cervical cancer cytology test technique. It can detect precancerous conditions and microbial infections. However, this technique entirely relies on manual operation and doctors' naked eye observation, resulting in a heavy workload and low accuracy rate. Recently, automatic pathological diagnosis has been developed to solve this problem. Cervical cell classification is a key technology in the intelligent cervical cancer diagnosis system. Training a deep neural network-based classification model requires a large amount of data. However, cervical cell labeling requires specialized physicians and the cost of labeling is high, resulting in a lack of sufficient labeling data in this field. To address this problem, we propose a method to ensure high accuracy in cervical cell classification with a small amount of labeled data by introducing manual features and a voting mechanism to achieve data expansion in semi-supervised learning. The method consists of three main steps, using a clarity function to filter out high-quality cervical cell images, annotating a small amount of them, and balancing the training data using a voting mechanism. With a small amount of labeled data, the accuracy of the proposed method in this paper can reach to 91.94%.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124511850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Lymphocyte Activation Gene 3 Single-Nucleotide Polymorphisms in Bone Marrow Failure Diseases 骨髓衰竭疾病中的淋巴细胞激活基因3单核苷酸多态性
Pub Date : 2022-02-27 DOI: 10.1155/2022/3528598
Yingying Sun, Qiuying Cao, Xiaoyu Zhao, Chunyan Liu, Z. Shao
Introduction Lymphocyte activation gene 3 (LAG3) is an inhibitory checkpoint protein expressed on activated T effector, T regulatory, and natural killer cells. The main function of LAG3 is the regulation of immune homeostasis. Several studies have suggested its role in malignant and autoimmune diseases. The objective of this study was to explore the association between LAG3 single-nucleotide polymorphisms (SNPs) and bone marrow failure diseases. Methods Sixty-two patients newly diagnosed with bone marrow failure diseases in the Hematology Department of Tianjin Medical University General Hospital between January 2019 and December 2020 and 16 healthy controls were enrolled in this study. SNPs in LAG3 were investigated by performing Sanger sequencing, and the association of the detected SNPs with bone marrow failure diseases was analyzed. Results Eleven SNPs were identified. Among them, the frequency of LAG3 rs1941928301 (C>T) was statistically different among the groups (P = 0.013). It was higher in the myelodysplastic syndrome (MDS) group than that in the severe aplastic anemia (SAA) group (P = 0.004) and that in the healthy control group (P = 0.009). Conclusions LAG3 rs1941928301 (C>T) might be associated with a higher risk of MDS. The detected LAG3 SNPs have no apparent effect on susceptibility to SAA and immune-related pancytopenia (IRP).
淋巴细胞活化基因3 (LAG3)是一种抑制检查点蛋白,在活化的T效应细胞、T调节细胞和自然杀伤细胞上表达。LAG3的主要功能是调节免疫稳态。一些研究表明它在恶性和自身免疫性疾病中的作用。本研究的目的是探讨LAG3单核苷酸多态性(snp)与骨髓衰竭疾病之间的关系。方法选取2019年1月至2020年12月天津医科大学总医院血液科62例新诊断为骨髓衰竭疾病的患者和16例健康对照。通过Sanger测序研究LAG3中的snp,并分析检测到的snp与骨髓衰竭疾病的相关性。结果共鉴定出11个snp。其中,LAG3 rs1941928301的频率(C>T)组间差异有统计学意义(P = 0.013)。骨髓增生异常综合征(MDS)组高于严重再生障碍性贫血(SAA)组(P = 0.004)和健康对照组(P = 0.009)。结论LAG3 rs1941928301 (C>T)可能与较高的MDS发病风险相关。检测到的LAG3 snp对SAA和免疫相关性全细胞减少症(IRP)的易感性无明显影响。
{"title":"Lymphocyte Activation Gene 3 Single-Nucleotide Polymorphisms in Bone Marrow Failure Diseases","authors":"Yingying Sun, Qiuying Cao, Xiaoyu Zhao, Chunyan Liu, Z. Shao","doi":"10.1155/2022/3528598","DOIUrl":"https://doi.org/10.1155/2022/3528598","url":null,"abstract":"Introduction Lymphocyte activation gene 3 (LAG3) is an inhibitory checkpoint protein expressed on activated T effector, T regulatory, and natural killer cells. The main function of LAG3 is the regulation of immune homeostasis. Several studies have suggested its role in malignant and autoimmune diseases. The objective of this study was to explore the association between LAG3 single-nucleotide polymorphisms (SNPs) and bone marrow failure diseases. Methods Sixty-two patients newly diagnosed with bone marrow failure diseases in the Hematology Department of Tianjin Medical University General Hospital between January 2019 and December 2020 and 16 healthy controls were enrolled in this study. SNPs in LAG3 were investigated by performing Sanger sequencing, and the association of the detected SNPs with bone marrow failure diseases was analyzed. Results Eleven SNPs were identified. Among them, the frequency of LAG3 rs1941928301 (C>T) was statistically different among the groups (P = 0.013). It was higher in the myelodysplastic syndrome (MDS) group than that in the severe aplastic anemia (SAA) group (P = 0.004) and that in the healthy control group (P = 0.009). Conclusions LAG3 rs1941928301 (C>T) might be associated with a higher risk of MDS. The detected LAG3 SNPs have no apparent effect on susceptibility to SAA and immune-related pancytopenia (IRP).","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132701576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691 姜黄素通过调控lncRNA LINC00691抑制甲状腺乳头状癌细胞增殖
Pub Date : 2022-02-26 DOI: 10.1155/2022/5946670
Zhihua Li, Youbing Gao, Lijun Li, Shanshan Xie
Papillary thyroid cancer (PTC) is a type of epithelial-derived differentiated TC that reportedly accounts for a majority of TCs. Curcumin, a polyphenolic compound and a member of the Zingiberaceae (ginger) family derived from turmeric plants, can exhibit anticancer effects. Herein, we aimed to investigate the effect of curcumin on PTC and elucidate underlying mechanisms. Accordingly, PTC B-CPAP cells were treated with curcumin, in combination with/without long noncoding RNA LINC00691 inhibition, to determine the effect of curcumin and its relationship with LINC00691 in PTC cells. We observed that curcumin treatment decreased B-CPAP cell proliferation and promoted apoptosis. Curcumin inhibited LINC00691 expression in B-CPAP cells. Curcumin administration or si-LINC00691 transfection alone promoted ATP levels, inhibited glucose uptake and lactic acid levels, and inhibited lactate dehydrogenase A and hexokinase 2 protein expression in B-CPAP cells, which were further enhanced by combination treatment. Moreover, curcumin administration or si-LINC00691 transfection alone inhibited p-Akt activity, further suppressed by combination treatment. Akt inhibition promoted apoptosis and suppressed the Warburg effect in B-CPAP cells. In conclusion, our findings indicate that curcumin promotes apoptosis and suppresses proliferation and the Warburg effect by inhibiting LINC00691 in B-CPAP cells. The precise molecular mechanism might be mediated through the Akt signaling pathway, providing a theoretical basis for the treatment of PTC with curcumin.
乳头状甲状腺癌(PTC)是一种上皮来源的分化型甲状腺癌,据报道占甲状腺癌的大多数。姜黄素是一种多酚类化合物,是姜科(生姜)家族的成员,从姜黄植物中提取,具有抗癌作用。在此,我们旨在研究姜黄素对PTC的影响并阐明其机制。因此,姜黄素联合/不联合长链非编码RNA LINC00691抑制PTC B-CPAP细胞,以确定姜黄素在PTC细胞中的作用及其与LINC00691的关系。我们观察到姜黄素治疗降低了B-CPAP细胞的增殖,促进了细胞凋亡。姜黄素抑制B-CPAP细胞中LINC00691的表达。姜黄素单独给药或si-LINC00691单独转染可提高B-CPAP细胞ATP水平,抑制葡萄糖摄取和乳酸水平,抑制乳酸脱氢酶A和己糖激酶2蛋白表达,联合处理可进一步增强。此外,姜黄素或si-LINC00691单独转染可抑制p-Akt活性,联合处理可进一步抑制p-Akt活性。Akt抑制可促进B-CPAP细胞凋亡,抑制Warburg效应。综上所述,我们的研究结果表明姜黄素通过抑制LINC00691促进B-CPAP细胞凋亡,抑制增殖和Warburg效应。其精确的分子机制可能通过Akt信号通路介导,为姜黄素治疗PTC提供理论依据。
{"title":"Curcumin Inhibits Papillary Thyroid Cancer Cell Proliferation by Regulating lncRNA LINC00691","authors":"Zhihua Li, Youbing Gao, Lijun Li, Shanshan Xie","doi":"10.1155/2022/5946670","DOIUrl":"https://doi.org/10.1155/2022/5946670","url":null,"abstract":"Papillary thyroid cancer (PTC) is a type of epithelial-derived differentiated TC that reportedly accounts for a majority of TCs. Curcumin, a polyphenolic compound and a member of the Zingiberaceae (ginger) family derived from turmeric plants, can exhibit anticancer effects. Herein, we aimed to investigate the effect of curcumin on PTC and elucidate underlying mechanisms. Accordingly, PTC B-CPAP cells were treated with curcumin, in combination with/without long noncoding RNA LINC00691 inhibition, to determine the effect of curcumin and its relationship with LINC00691 in PTC cells. We observed that curcumin treatment decreased B-CPAP cell proliferation and promoted apoptosis. Curcumin inhibited LINC00691 expression in B-CPAP cells. Curcumin administration or si-LINC00691 transfection alone promoted ATP levels, inhibited glucose uptake and lactic acid levels, and inhibited lactate dehydrogenase A and hexokinase 2 protein expression in B-CPAP cells, which were further enhanced by combination treatment. Moreover, curcumin administration or si-LINC00691 transfection alone inhibited p-Akt activity, further suppressed by combination treatment. Akt inhibition promoted apoptosis and suppressed the Warburg effect in B-CPAP cells. In conclusion, our findings indicate that curcumin promotes apoptosis and suppresses proliferation and the Warburg effect by inhibiting LINC00691 in B-CPAP cells. The precise molecular mechanism might be mediated through the Akt signaling pathway, providing a theoretical basis for the treatment of PTC with curcumin.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"234 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121481914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Magnetic Resonance Imaging of Contrast-Induced Acute Renal Injury and Related Pathological Alterations In Vivo 造影剂诱导急性肾损伤及相关病理改变的磁共振成像研究
Pub Date : 2022-02-26 DOI: 10.1155/2022/6984200
Yanfei Li, Dafa Shi, Haoran Zhang, Xiang Yao, Ke Ren
Background The definitive mechanisms of CI-AKI include contrast medium (CM) nephrotoxicity and CM disturbances in renal blood flow, but how the immune system responds to CM has rarely been mentioned in previous studies, and different cell death pathways have not been clearly distinguished. Aim To confirm whether MRI detect early CI-AKI and to investigate whether immunity-related responses, pyroptosis, and mitophagy participate in contrast-induced acute renal injury (CI-AKI). Methods C57BL/6 mice with CI-AKI were established by tail vein injection of iodixanol 320. Magnetic resonance imaging of 9.4 T scanner and microscopic appearance of renal H&E staining were tools to test the occurrence of CI-AKI at different times. Immunohistochemistry and NGAL were used to examine the immune responses in the kidneys with CI-AKI. Transmission electron microscopy and western blot methods were used to distinguish various cell death pathways in CI-AKI. Key Results. The densitometry of T2WI, DTI, and BOLD presents CI-AKI in a regular way. The microscopic appearance presents the strongest renal damage in CI-AKI mice that existed between 12 h (P < 0.0001) and 24 h (P < 0.05) after contrast medium (CM) injection. Strong correlation may exist between MRI densitometry (T2WI, DTI, and BOLD) and pathology. Neutrophil and macrophage chemotaxis occurred in CI-AKI, and we observed that Ly6G was the strongest at 48 h (P < 0.0001). Pyroptosis (Nlrp3/caspase-1, P < 0.05), mitophagy (BNIP/Nix, P < 0.05), and apoptosis (Bax, P < 0.05) occurred in CI-AKI. Conclusions fMRI can detect early CI-AKI immediately after CM injection. NLRP3 inflammasomes are involved in CI-AKI, and mitophagy may play a role in mitigating kidney injury. The mitochondrion is one of the key organelles in the tubular epithelium implicated in CI-AKI.
CI-AKI的明确机制包括造影剂(CM)肾毒性和造影剂对肾血流的干扰,但在以往的研究中很少提到免疫系统对CM的反应,不同的细胞死亡途径也没有明确区分。目的探讨MRI是否能早期检测到造影剂诱导的急性肾损伤(CI-AKI),探讨免疫相关反应、焦亡和线粒体自噬是否参与造影剂诱导的急性肾损伤(CI-AKI)。方法采用尾静脉注射碘沙醇320建立CI-AKI小鼠C57BL/6模型。mri 9.4 T扫描和肾H&E染色镜检是检测不同时间CI-AKI发生的工具。采用免疫组织化学和NGAL检测CI-AKI肾脏的免疫反应。采用透射电镜和western blot方法区分CI-AKI细胞的各种死亡途径。关键的结果。T2WI、DTI、BOLD的密度测定显示CI-AKI具有规律性。造影剂(CM)注射后12 h ~ 24 h (P < 0.05), CI-AKI小鼠肾损伤在显微镜下表现为最强。MRI密度测量(T2WI, DTI和BOLD)与病理之间可能存在很强的相关性。CI-AKI发生中性粒细胞和巨噬细胞趋化,我们观察到Ly6G在48 h时最强(P < 0.0001)。CI-AKI发生焦亡(Nlrp3/caspase-1, P < 0.05)、线粒体自噬(BNIP/Nix, P < 0.05)和细胞凋亡(Bax, P < 0.05)。结论fMRI可在CM注射后立即发现早期CI-AKI。NLRP3炎性小体参与CI-AKI,线粒体自噬可能在减轻肾损伤中发挥作用。线粒体是参与CI-AKI的小管上皮的关键细胞器之一。
{"title":"Magnetic Resonance Imaging of Contrast-Induced Acute Renal Injury and Related Pathological Alterations In Vivo","authors":"Yanfei Li, Dafa Shi, Haoran Zhang, Xiang Yao, Ke Ren","doi":"10.1155/2022/6984200","DOIUrl":"https://doi.org/10.1155/2022/6984200","url":null,"abstract":"Background The definitive mechanisms of CI-AKI include contrast medium (CM) nephrotoxicity and CM disturbances in renal blood flow, but how the immune system responds to CM has rarely been mentioned in previous studies, and different cell death pathways have not been clearly distinguished. Aim To confirm whether MRI detect early CI-AKI and to investigate whether immunity-related responses, pyroptosis, and mitophagy participate in contrast-induced acute renal injury (CI-AKI). Methods C57BL/6 mice with CI-AKI were established by tail vein injection of iodixanol 320. Magnetic resonance imaging of 9.4 T scanner and microscopic appearance of renal H&E staining were tools to test the occurrence of CI-AKI at different times. Immunohistochemistry and NGAL were used to examine the immune responses in the kidneys with CI-AKI. Transmission electron microscopy and western blot methods were used to distinguish various cell death pathways in CI-AKI. Key Results. The densitometry of T2WI, DTI, and BOLD presents CI-AKI in a regular way. The microscopic appearance presents the strongest renal damage in CI-AKI mice that existed between 12 h (P < 0.0001) and 24 h (P < 0.05) after contrast medium (CM) injection. Strong correlation may exist between MRI densitometry (T2WI, DTI, and BOLD) and pathology. Neutrophil and macrophage chemotaxis occurred in CI-AKI, and we observed that Ly6G was the strongest at 48 h (P < 0.0001). Pyroptosis (Nlrp3/caspase-1, P < 0.05), mitophagy (BNIP/Nix, P < 0.05), and apoptosis (Bax, P < 0.05) occurred in CI-AKI. Conclusions fMRI can detect early CI-AKI immediately after CM injection. NLRP3 inflammasomes are involved in CI-AKI, and mitophagy may play a role in mitigating kidney injury. The mitochondrion is one of the key organelles in the tubular epithelium implicated in CI-AKI.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121655799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohistochemical Analysis of Postburn Scars following Treatment Using Dermal Substitutes 皮肤代用品治疗烧伤后瘢痕的免疫组织化学分析
Pub Date : 2022-02-25 DOI: 10.1155/2022/3686863
M. Y. Lee, Hyunchul Kim, I. Kwak, Young-Gyu Jang, Y. Choi
Background Post-burn hypertrophic scars commonly occur after burns. Studies that compare dermal substitutes with other treatment methods are insufficient. The purpose was to analyze the histopathological differences in hypertrophic burn scars after Matriderm®+split-thickness skin graft (STSG) and compare with AlloDerm®+STSG, STSG, full-thickness skin graft (FTSG), and normal skin. Methods Samples of unburned, normal skin and deep 2nd or 3rd degree burns were obtained from patients who experienced a burn injury in the past to at least 6 months before biopsy, which was performed between 2011 and 2012. All subjects received >6 months of treatment before the biopsy. Intervention groups were normal (63), STSG (28), FTSG (6), Matriderm® (11), and AlloDerm® (18). Immunohistochemical analyses of elastin, collagen I, collagen III, cluster of differentiation 31 (CD31), smooth muscle actin (α-SMA), and laminin from scar and control tissues were performed and compared. Results α-SMA vascular quantity and vessel width, stromal CD31, and basement membrane laminin expression were not significantly different between normal and intervention groups. Matriderm® group showed no significant difference in elastin, collagen III, stromal CD31 and α-SMA, CD31 vessel width, stromal α-SMA, vessel quantity and width, and laminin length compared to the normal group, meaning they were not significantly different from the normal skin traits. Conclusion Dermal substitutes may be an optimal alternative to address the cosmetic and functional limitations posed by other treatment methods.
背景:烧伤后增生性瘢痕常见于烧伤后。将真皮替代品与其他治疗方法进行比较的研究是不够的。目的分析Matriderm®+裂厚皮移植(STSG)后增生性烧伤瘢痕的组织病理学差异,并与AlloDerm®+STSG、STSG、全层皮移植(FTSG)和正常皮肤进行比较。方法选取2011年至2012年在活检前至少6个月有过烧伤经历的患者,选取未烧伤、正常皮肤和深度2度或3度烧伤标本。所有受试者在活检前均接受了>6个月的治疗。干预组为normal(63)、STSG(28)、FTSG(6)、Matriderm®(11)、AlloDerm®(18)。对瘢痕组织和对照组织中的弹性蛋白、ⅰ型胶原、ⅲ型胶原、CD31簇、平滑肌肌动蛋白(α-SMA)和层粘连蛋白进行免疫组化分析并进行比较。结果α-SMA血管数量、血管宽度、间质CD31、基底膜层粘连蛋白表达在正常组和干预组间无显著差异。Matriderm®组与正常组相比,弹性蛋白、III型胶原、间质CD31和α-SMA、CD31血管宽度、间质α-SMA、血管数量和宽度、层粘连蛋白长度均无显著差异,与正常组相比无显著差异。结论真皮替代品可能是解决其他治疗方法在美容和功能上的局限性的最佳选择。
{"title":"Immunohistochemical Analysis of Postburn Scars following Treatment Using Dermal Substitutes","authors":"M. Y. Lee, Hyunchul Kim, I. Kwak, Young-Gyu Jang, Y. Choi","doi":"10.1155/2022/3686863","DOIUrl":"https://doi.org/10.1155/2022/3686863","url":null,"abstract":"Background Post-burn hypertrophic scars commonly occur after burns. Studies that compare dermal substitutes with other treatment methods are insufficient. The purpose was to analyze the histopathological differences in hypertrophic burn scars after Matriderm®+split-thickness skin graft (STSG) and compare with AlloDerm®+STSG, STSG, full-thickness skin graft (FTSG), and normal skin. Methods Samples of unburned, normal skin and deep 2nd or 3rd degree burns were obtained from patients who experienced a burn injury in the past to at least 6 months before biopsy, which was performed between 2011 and 2012. All subjects received >6 months of treatment before the biopsy. Intervention groups were normal (63), STSG (28), FTSG (6), Matriderm® (11), and AlloDerm® (18). Immunohistochemical analyses of elastin, collagen I, collagen III, cluster of differentiation 31 (CD31), smooth muscle actin (α-SMA), and laminin from scar and control tissues were performed and compared. Results α-SMA vascular quantity and vessel width, stromal CD31, and basement membrane laminin expression were not significantly different between normal and intervention groups. Matriderm® group showed no significant difference in elastin, collagen III, stromal CD31 and α-SMA, CD31 vessel width, stromal α-SMA, vessel quantity and width, and laminin length compared to the normal group, meaning they were not significantly different from the normal skin traits. Conclusion Dermal substitutes may be an optimal alternative to address the cosmetic and functional limitations posed by other treatment methods.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124294312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2 TWIST1-EP300通过激活COL1A2表达加速胃癌细胞对阿帕替尼的耐药性
Pub Date : 2022-02-22 DOI: 10.1155/2022/5374262
Gang Yu, Wanjing Chen, Xianghua Li, Liang Yu, Yanyan Xu, Q. Ruan, Yawei He, Yong Wang
The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been investigated before. The purpose of this study was to explore the potential factors associated with COL1A2 regulation on GC cell apatinib resistance in vitro. With the aid of the Oncomine database and integrated bioinformatics methods, we identified COL1A2 overexpression in GC and its prognostic value. Mechanistically, the COL1A2 promoter has a distinct H3K27ac modification site and that E1A binding protein p300 (EP300) and twist family bHLH transcription factor 1 (TWIST1) can bind to the COL1A2 promoter, which in turn transcriptionally activated COL1A2 expression. In addition, overexpression of COL1A2 significantly promoted resistance to apatinib in GC cells, but knockdown of EP300 or TWIST1 remarkably inhibited COL1A2 expression and promoted sensitivity of GC cells to apatinib. Our findings demonstrated that the combination of EP300 and TWIST1 has a synergistically regulatory effect on COL1A2 expression, thus contributing to apatinib resistance in GC cells.
胶原I型α (COL1A)与化疗耐药之间的关系已在癌症中得到证实。然而,COL1A2在胃癌(GC)细胞对阿帕替尼(一种高选择性血管内皮生长因子受体2的小分子抑制剂)耐药中的具体作用尚未被研究。本研究旨在探讨COL1A2调控GC细胞体外阿帕替尼耐药的可能因素。借助Oncomine数据库和综合生物信息学方法,我们确定了COL1A2在GC中的过表达及其预后价值。从机制上讲,COL1A2启动子具有不同的H3K27ac修饰位点,E1A结合蛋白p300 (EP300)和twist家族bHLH转录因子1 (TWIST1)可以结合到COL1A2启动子上,从而转录激活COL1A2的表达。此外,COL1A2过表达可显著促进GC细胞对阿帕替尼的耐药,而EP300或TWIST1的敲低可显著抑制COL1A2的表达,提高GC细胞对阿帕替尼的敏感性。我们的研究结果表明,EP300和TWIST1联合对COL1A2表达具有协同调节作用,从而促进了GC细胞对阿帕替尼的耐药。
{"title":"TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2","authors":"Gang Yu, Wanjing Chen, Xianghua Li, Liang Yu, Yanyan Xu, Q. Ruan, Yawei He, Yong Wang","doi":"10.1155/2022/5374262","DOIUrl":"https://doi.org/10.1155/2022/5374262","url":null,"abstract":"The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been investigated before. The purpose of this study was to explore the potential factors associated with COL1A2 regulation on GC cell apatinib resistance in vitro. With the aid of the Oncomine database and integrated bioinformatics methods, we identified COL1A2 overexpression in GC and its prognostic value. Mechanistically, the COL1A2 promoter has a distinct H3K27ac modification site and that E1A binding protein p300 (EP300) and twist family bHLH transcription factor 1 (TWIST1) can bind to the COL1A2 promoter, which in turn transcriptionally activated COL1A2 expression. In addition, overexpression of COL1A2 significantly promoted resistance to apatinib in GC cells, but knockdown of EP300 or TWIST1 remarkably inhibited COL1A2 expression and promoted sensitivity of GC cells to apatinib. Our findings demonstrated that the combination of EP300 and TWIST1 has a synergistically regulatory effect on COL1A2 expression, thus contributing to apatinib resistance in GC cells.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129610270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC ESCC中MACC1/c-Met/Cyclin D1轴表达与预后的关系
Pub Date : 2022-02-22 DOI: 10.1155/2022/9651503
Yan Shi, Meng Li, Hui Wang, Chao Li, Wencong Liu, Yongxiang Gao, Bowei Wang, Jiajun Song, Yuqing Ma
Background Esophageal cancer is one of the most common malignant tumors of the digestive system, with high incidence and mortality. Methods Immunohistochemical method was used to detect the expression of MACC1, c-Met, and cyclin D1 in ESCC and its adjacent tissues. Statistical analysis was done by SPSS 23.0. Results The high expression of MACC1 and cyclin D1 was significantly correlated with tumor size. High c-Met expression was associated with patient ethnicity. MACC1 expression was positively correlated with both c-Met and cyclin D1. c-Met expression was also positively correlated with cyclin D1. Patients with high expression of MACC1 and c-Met had worse OS; patients with high c-Met expression also had worse PFS. Conclusion MACC1, c-Met, and cyclin D1 proteins are closely related to the occurrence and development of esophageal squamous cell carcinoma. MACC1 may affect the prognosis of ESCC by regulating the expression of the c-Met/cyclin D1 axis.
食管癌是消化道最常见的恶性肿瘤之一,具有较高的发病率和死亡率。方法采用免疫组化方法检测ESCC及其邻近组织中MACC1、c-Met、cyclin D1的表达。采用SPSS 23.0进行统计分析。结果MACC1和cyclin D1的高表达与肿瘤大小有显著相关性。高c-Met表达与患者种族有关。MACC1表达与c-Met和cyclin D1均呈正相关。c-Met的表达也与cyclin D1呈正相关。MACC1和c-Met高表达的患者OS较差;高c-Met表达的患者PFS也较差。结论MACC1、c-Met、cyclin D1蛋白与食管鳞状细胞癌的发生发展密切相关。MACC1可能通过调节c-Met/cyclin D1轴的表达影响ESCC的预后。
{"title":"The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC","authors":"Yan Shi, Meng Li, Hui Wang, Chao Li, Wencong Liu, Yongxiang Gao, Bowei Wang, Jiajun Song, Yuqing Ma","doi":"10.1155/2022/9651503","DOIUrl":"https://doi.org/10.1155/2022/9651503","url":null,"abstract":"Background Esophageal cancer is one of the most common malignant tumors of the digestive system, with high incidence and mortality. Methods Immunohistochemical method was used to detect the expression of MACC1, c-Met, and cyclin D1 in ESCC and its adjacent tissues. Statistical analysis was done by SPSS 23.0. Results The high expression of MACC1 and cyclin D1 was significantly correlated with tumor size. High c-Met expression was associated with patient ethnicity. MACC1 expression was positively correlated with both c-Met and cyclin D1. c-Met expression was also positively correlated with cyclin D1. Patients with high expression of MACC1 and c-Met had worse OS; patients with high c-Met expression also had worse PFS. Conclusion MACC1, c-Met, and cyclin D1 proteins are closely related to the occurrence and development of esophageal squamous cell carcinoma. MACC1 may affect the prognosis of ESCC by regulating the expression of the c-Met/cyclin D1 axis.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121735296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer TLR4激动剂和缺氧协同促进人上皮性卵巢癌TLR4/NF-κB/HIF-1α环的形成
Pub Date : 2021-08-13 DOI: 10.1155/2022/4201262
Bin Zhao, Xiulong Niu, S. Huang, Jing Yang, Yiying Wei, X. Wang, Junhong Wang, Yue Wang, Xiaoqin Guo
Inflammation and hypoxia are involved in numerous cancer progressions. Reportedly, the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway and hypoxia-inducible factor-1α (HIF-1α) are activated and closely related to the chemoresistance and poor prognosis of epithelial ovarian cancer (EOC). However, the potential correlation between TLR4/NF-κB and HIF-1α remains largely unknown in EOC. In our study, the possible positive correlation among TLR4, NF-κB, and HIF-1α proteins was investigated in the EOC tissues. Our in vitro results demonstrated that LPS can induce and activate HIF-1α through the TLR4/NF-κB signaling in A2780 and SKOV3 cells. Moreover, hypoxia-induced TLR4 expression and the downstream transcriptional activity of NF-κB were HIF-1α-dependent. The cross talk between the TLR4/NF-κB signaling pathway and HIF-1α was also confirmed in the nude mice xenograft model. Therefore, we first proposed the formation of a TLR4/NF-κB/HIF-1α loop in EOC. The positive feedback loop enhanced the susceptibility and responsiveness to inflammation and hypoxia, which synergistically promote the initiation and progression of EOC. The novel mechanism may act as a future therapeutic candidate for the treatment of EOC.
炎症和缺氧与许多癌症进展有关。据报道,toll样受体4 (TLR4)/核因子κB (NF-κB)通路和缺氧诱导因子1α (HIF-1α)被激活,与上皮性卵巢癌(EOC)的化疗耐药和预后不良密切相关。然而,在EOC中,TLR4/NF-κB和HIF-1α之间的潜在相关性在很大程度上仍然未知。本研究探讨了在EOC组织中TLR4、NF-κB和HIF-1α蛋白之间可能存在的正相关关系。我们的体外实验结果表明,LPS可以通过TLR4/NF-κB信号通路诱导和激活A2780和SKOV3细胞中的HIF-1α。此外,缺氧诱导的TLR4表达和NF-κB下游转录活性依赖于hif -1α。在裸鼠异种移植瘤模型中也证实了TLR4/NF-κB信号通路与HIF-1α之间的串扰。因此,我们首次提出在EOC中形成TLR4/NF-κB/HIF-1α环。正反馈回路增强了炎症和缺氧的易感性和反应性,协同促进了EOC的发生和发展。这种新机制可能作为未来治疗EOC的候选疗法。
{"title":"TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer","authors":"Bin Zhao, Xiulong Niu, S. Huang, Jing Yang, Yiying Wei, X. Wang, Junhong Wang, Yue Wang, Xiaoqin Guo","doi":"10.1155/2022/4201262","DOIUrl":"https://doi.org/10.1155/2022/4201262","url":null,"abstract":"Inflammation and hypoxia are involved in numerous cancer progressions. Reportedly, the toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway and hypoxia-inducible factor-1α (HIF-1α) are activated and closely related to the chemoresistance and poor prognosis of epithelial ovarian cancer (EOC). However, the potential correlation between TLR4/NF-κB and HIF-1α remains largely unknown in EOC. In our study, the possible positive correlation among TLR4, NF-κB, and HIF-1α proteins was investigated in the EOC tissues. Our in vitro results demonstrated that LPS can induce and activate HIF-1α through the TLR4/NF-κB signaling in A2780 and SKOV3 cells. Moreover, hypoxia-induced TLR4 expression and the downstream transcriptional activity of NF-κB were HIF-1α-dependent. The cross talk between the TLR4/NF-κB signaling pathway and HIF-1α was also confirmed in the nude mice xenograft model. Therefore, we first proposed the formation of a TLR4/NF-κB/HIF-1α loop in EOC. The positive feedback loop enhanced the susceptibility and responsiveness to inflammation and hypoxia, which synergistically promote the initiation and progression of EOC. The novel mechanism may act as a future therapeutic candidate for the treatment of EOC.","PeriodicalId":313227,"journal":{"name":"Analytical Cellular Pathology (Amsterdam)","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128504190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
期刊
Analytical Cellular Pathology (Amsterdam)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1